WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell has been selected as Best Consumer Product Winner in Digital Healthcare by Juniper Research in its annual Future Digital Awards for Technology & Innovation. Juniper’s Future Digital Awards recognize innovative and promising products across the consumer technology sectors of Digital Healthcare, Automotive, Smart Homes and Wearables.
“We are thrilled that Quell was selected as a winner in Future Digital Awards 2016, further validating the importance of the product’s role in leading the technology advances in Digital Health”
“We are thrilled that Quell was selected as a winner in Future Digital Awards 2016, further validating the importance of the product’s role in leading the technology advances in Digital Health,” said Frank McGillin, Senior Vice President and General Manager, Consumer of NeuroMetrix, Inc. “We are honored to be one of the select group of winners that include Tesla Autopilot and the Amazon Alexa.”
Quell is an easy-to-use, over-the-counter device for relief of chronic pain. This wearable device utilizes NeuroMetrix’s patented neurostimulation technology to provide pain relief. In a recent clinical study, Quell improved chronic pain in 81% of participants. Quell is currently available through select healthcare professionals, retailers, and online at www.QuellRelief.com.
About Juniper Research
Juniper Research, based in Basingstoke, UK, provides research and analytical services to the global hi-tech communications sector, providing consultancy, analyst reports and industry commentary. The Juniper Future Digital Awards were decided by a panel of expert judges based on a number of criteria including product features and user benefits, innovation, commercial partnerships, commercial launches, certification & compliance, and potential future business development.
About NeuroMetrix
NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com.
Contacts
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com